Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

NGR-human tumour necrosis factor

EU orphan designation number: EU/3/09/686   
Active ingredient: NGR-human tumour necrosis factor
Indication: Treatment of hepatocellular carcinoma
Sponsor: MolMed S.p.A.
Via Olgettina 58, 20132 Milano, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/11/2009 Orphan designation EMEA/OD/070/09 (2009)8766 of 09/11/2009